Title of article :
Candida auris and COVID-19: A health threatening combination
Author/Authors :
khojasteh ، shaghayegh Department of Medical Mycology - School of Medicine, Invasive Fungi Research Center, Communicable Diseases Institute - Mazandaran University of Medical Sciences , jafarzadeh ، Jalal Department of Medical Mycology and Parasitology - School of Medicine - Babol University of Medical Sciences , Hosseini ، Abdollah Toxoplasmosis Research Center, Communicable Diseases Institute - Mazandaran University of Medical Sciences , Haghani ، Iman Department of Medical Mycology - School of Medicine, Invasive Fungi Research Center, Communicable Diseases Institute - Mazandaran University of Medical Sciences , Turki ، Habibollah Molecular Medecine Research Center, Hormozgan Health Institute - Hormozgan University of Medical Sciences , Aghaei Gharehbolagh ، Sanaz Department of Medical Parasitology and Mycology - School of Public Health - Tehran University of Medical Sciences , Abastabar ، Mahdi Department of Medical Mycology - School of Medicine, Invasive Fungi Research Center, Communicable Diseases Institute - Mazandaran University of Medical Sciences , Mahmoudi ، Shahram Department of Parasitology and Mycology - School of Medicine - Iran University of Medical Sciences
Abstract :
Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic s potential effect on antifungal drug resistance.
Keywords :
Antifungal resistance , Candida auris , Co , infection , COVID , 19 , SARS , CoV , 2
Journal title :
Current Medical Mycology
Journal title :
Current Medical Mycology
